Skip to main content

People in the News: Oct 4, 2011

Premium

David Ledbetter has joined CombiMatrix's medical advisory board.

Ledbetter is a director of the International Standards for Cytogenomic Arrays Consortium and currently serves as the executive vice president and chief scientific officer at Geisinger Health System. He has also held academic and genetics-related positions at Emory University School of Medicine, the University of Chicago, the National Institutes of Health, and Baylor College of Medicine.

Ledbetter holds a BS in psychology from Tulane University and a PhD in behavioral genetics and psychology from the University of Texas. He is a founding fellow of the American College of Medical Genetics and has served on the boards of directors of the American Society of Human Genetics and the ACMG.

BioArray News interviewed Ledbetter about his role at Geisinger earlier this year (BAN 1/11/11).


Expression Analysis has hired Tyler Aldredge as vice president of laboratory operations. Aldredge was most recently director of laboratory operations at Genzyme Genetics. Prior to that, he held positions at the Broad Institute, the Harvard University Center for Genomic Research, Sanofi, Codon Devices, and Genome Therapeutics.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.